Exenatide

insulin ; Felis catus







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31479925 A once-monthly GLP-1 receptor agonist for treatment of diabetic cats. 2020 Jan 1
2 30015124 Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus. 2018 Oct 2
3 27136422 A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats. 2016 1
4 25648286 Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats. 2015 Apr 1
5 21645806 The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats. 2011 Jul 4